|
Asmacure Ltee to Present at the 2011 BIO Business Forum During the Annual BIO …
PR Newswire (press release) QUEBEC CITY, June 22, 2011 /PRNewswire/ — Asmacure Ltee, a clinical-stage biopharmaceutical company focused on the development of nicotinic receptor agonists for the treatment of asthma and other inflammatory diseases, announced today that CEO Martin … |
View full post on asthma – Google News